US 7928217
Nuclease resistant double-stranded ribonucleic acid
granted A61PA61P43/00
Quick answer
US patent 7928217 (Nuclease resistant double-stranded ribonucleic acid) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P43/00